ANTENNA BASES

Brand Owner (click to sort) Address Description
C Global Cellular, Inc. Building B, Unit 100
6485 Shiloh Road
Alpharetta GA 30005
cellular telephone accessories, antenna bases, antenna ...
CELLAIRIS Global Cellular, Inc. 6485 Shiloh Road
Building B, Unit 100
Alpharetta GA 30005
[ Cellular telephones, ] cellular equipment ...
CELLAIRIS.COM Global Cellular, Inc. Bldg. B-100
6485 Shiloh Road
Alpharetta GA 30005
Cellular telephone accessories, antenna bases, antenna ...
DRAGON FLY Global Cellular, Inc. Building B, Unit 100
6485 Shiloh Road
Alpharetta GA 30005
Carrying cases for cellular phones, pouch ...
DRAGONFLY Global Cellular, Inc. 6485 Shiloh Road
Building B, Unit 100
Alpharetta GA 30005
Cellular telephone accessories, antenna bases, antenna ...
ESSENTIALS FOR YOUR LIFESTYLE Wireless Essentials, Inc. 5910 Shiloh Road East
Suite 107
Alpharetta GA 30005
Cellular telephone accessories namely, antenna bases, ...
INAX INAX CORPORATION 3-6, KOIE HONMACHI, TOKONAME-SHI
AICHI
JP
SATELLITE BROADCASTING ANTENNAS; EARTH STATIONS COMPRISED ...
INAX INAX CORPORATION 3-6, KOIE HONMACHI
TOKONAME-SHI, AICHI
JP
SATELLITE BROADCASTING ANTENNAS; EARTH STATIONS COMPRISED ...
WICKED MOBILE Global Cellular, Inc. Building B, Unit 100
6485 Shiloh Road
Alpharetta GA 30005
Cellular telephone accessories, antenna bases, antenna ...
WIRELESS ESSENTIALS Wireless Essentials, Inc. Suite 107 5910 Shiloh Road East
Alpharetta GA 30005
Cellular telephone accessories namely, antenna bases, ...
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention provides novel synthetic oligonucleotide sequences (hereinafter sequence) of 3 to 9 bases in length comprising one or more non-DNA bases wherein the bases are nebularine, hypoxanthine, or uracil, or combinations of nebularine, hypoxanthine and uracil bases. These sequences optionally further comprise one or more guanine bases or one or more thymine bases, or combinations thereof. The present invention also provides methods of using these compositions to induce responses in cells, and to treat diseases and conditions characterized by undesired cellular proliferation such as autoimmune disease, lymphoproliferative disease, inflammation or cancer.